CHI Advisors LLC current holdings: USA Stocks
CHI Advisors LLC reported $0.18 billion in share positions in stocks (listed in the US), 14 positions, in its Form 13F for the quarter ended 2023-09-30; the largest are PLRX, RPTX, CGEM.
- PLRX: Country of operation United States; Class COM; Shares 3,014,199; Value $52,266,211.
- RPTX: Country of operation —; Class COM; Shares 2,966,674; Value $35,837,422.
- CGEM: Country of operation United States; Class COM; Shares 3,414,189; Value $30,898,410.
- LRMR: Country of operation United States; Class COM; Shares 3,414,468; Value $13,487,148.
Form 13F-HR as filed (SEC CIK 1791468): quarter ended 2023-09-30, filed 2023-11-13. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
Performance is each holding's price change from its close on the 2023-09-30 quarter end to its latest retained close (2026-09-29, or the date shown for a stock that stopped trading). Price only; dividends are not included. A stock that split in the period is restated by the split ratio in its own Form 8-K; a dash marks a holding with no retained closes.
| Stock | Country of operation | Class | Shares | Value | % of listed | Quarter end | Filed | Performance |
|---|---|---|---|---|---|---|---|---|
| PLRX PLIANT THERAPEUTICS INC | United States | COM | 3,014,199 | $52,266,211 | 28.67% | 2023-09-30 | 2023-11-13 | — split 2025-02-10, ratio not on file |
| RPTX REPARE THERAPEUTICS INC | COM | 2,966,674 | $35,837,422 | 19.66% | 2023-09-30 | 2023-11-13 | ||
| CGEM CULLINAN ONCOLOGY INC | United States | COM | 3,414,189 | $30,898,410 | 16.95% | 2023-09-30 | 2023-11-13 | +68.29% |
| LRMR LARIMAR THERAPEUTICS INC | United States | COM | 3,414,468 | $13,487,148 | 7.40% | 2023-09-30 | 2023-11-13 | -20.51% |
| KROS KEROS THERAPEUTICS INC | United States | COM | 407,633 | $12,995,340 | 7.13% | 2023-09-30 | 2023-11-13 | — split 2024-12-12, ratio not on file |
| RARE ULTRAGENYX PHARMACEUTICAL IN | United States | COM | 215,000 | $7,664,750 | 4.20% | 2023-09-30 | 2023-11-13 | — split 2025-12-29, ratio not on file |
| CMPX COMPASS THERAPEUTICS INC | United States | COM | 2,829,712 | $5,574,532 | 3.06% | 2023-09-30 | 2023-11-13 | — split 2026-04-27, ratio not on file |
| MLYS MINERALYS THERAPEUTICS INC | United States | COM | 568,379 | $5,405,284 | 2.97% | 2023-09-30 | 2023-11-13 | — split 2025-09-02, ratio not on file |
| SYRS SYROS PHARMACEUTICALS INC | United States | COM NEW | 1,299,359 | $5,119,170 | 2.81% | 2023-09-30 | 2023-11-13 | |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | Switzerland | CLASS A ORD | 60,000 | $3,420,000 | 1.88% | 2023-09-30 | 2023-11-13 | — split 2025-09-29, ratio not on file |
| OVID OVID THERAPEUTICS INC | United States | COM | 864,822 | $3,320,916 | 1.82% | 2023-09-30 | 2023-11-13 | — split 2024-06-17, ratio not on file |
| SGMT SAGIMET BIOSCIENCES INC | United States | COM SER A | 348,842 | $3,069,810 | 1.68% | 2023-09-30 | 2023-11-13 | — split 2024-01-22, ratio not on file |
| BDTX BLACK DIAMOND THERAPEUTICS I | United States | COM | 720,000 | $2,066,400 | 1.13% | 2023-09-30 | 2023-11-13 | -34.84% |
| IRON DISC MEDICINE INC | United States | COM | 25,000 | $1,174,500 | 0.64% | 2023-09-30 | 2023-11-13 | — split 2024-04-01, ratio not on file |
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||